CDW CDW
Technology · Information Technology Services · Synthos Deep Dive · 2026-07-03
The Overview
CDW is the company that big businesses, schools, hospitals, and government agencies call when they need to buy and set up their computers, servers, software, and networking gear. It doesn't make the technology — it's the trusted middleman (a "reseller") that sources it from brands like Dell, Microsoft, Cisco and Apple, adds advice and services, and takes a cut. It's a solid, boring business.
Is the stock cheap or expensive? Cheap-ish. You pay about $16 for every $1 of annual profit — well below the market average — and you collect a ~1.9% dividend while you wait. The catch: the business barely grows (sales creep up only a few percent a year), it keeps only about 5 cents of profit per sales dollar (razor-thin), and it swings hard with the economy — the stock is down about a quarter over the past year while the market rose.
Our verdict is Watch: nothing is broken, the price is fair, but there's no engine to make it race ahead and no expert on our panel is banging the table for it. Here's what the three scores mean in plain words:
- Downside Risk 5/10 (middle). Low-drama stock and a cheap price cushion the downside, but it carries real debt and its sales rise and fall with corporate tech budgets.
- Growth Quality 5/10 (average). Steady and profitable in dollar terms, but slow-growing and thin-margined — a good distributor, not a great business.
- Exponential Potential 3/10 (low). This is a mature, low-margin middleman. Don't expect it to multiply your money.
The one big worry: if companies and governments cut their tech spending in a downturn, CDW's sales and profits fall fast — this stock already dropped nearly in half from its peak once.
Putting a number on it: our fair-value estimate is $150 against a current price of $147.69 — real upside if our numbers are right.
Our summary metrics
Cheap at ~16× and low-beta, but 3.0× net-debt/EBITDA and deep IT-spend cyclicality (−48% max drawdown).
Only ~5% rev / ~9% EPS forward CAGR, thin 21% gross & ~5% net margin — a distributor, not a compounder.
Low-margin reseller in a mature market; growth flat-to-decelerating and $17B cap has no multibagger runway.
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Exponential Potential
Low-margin reseller in a mature market; growth flat-to-decelerating and $17B cap has no multibagger runway.
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $150 (high $180 / low $123; 1 Strong Buy · 12 Buy · 5 Hold · 0 Sell) — context, not our anchor |
| Valuation | 16× trailing EPS · ~12× FY27E · EV/S 0.99× · EV/EBITDA 12.2× — genuinely cheap for the sector |
| Technicals | Downtrend/basing — $133, −27% off 52-wk high, below 200-DMA, RSI 55, −26% 12-mo (SPY +21%) |
| Conviction | Low — zero expert voices in the KB; call rests on fundamentals + quant only |
| Position sizing | If owned at all, small (~1–2%) value/income sleeve — not a core or growth holding |
What the experts actually said
No independent expert claims in the Synthos knowledge base yet for CDW — this dive is fundamentals- and technicals-driven, not panel-driven.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $147.69, 7% above the 50-day average ($138), 12% above the 200-day average ($132) — an uptrend. 14% below the 52-week high of $171, 49% above the 52-week low of $99.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $147.69 is currently inside the band (band $129–$151).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 59.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently above its signal line by 0.94, positive momentum.
Relative performance vs S&P 500 & its sector (XLK (sector)), set to 100 a year ago
Solid = CDW · dashed = S&P 500 · dotted = XLK (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What it is
CDW Corporation (Nasdaq: CDW) is a multi-brand provider of information-technology products and services to business, government, education and healthcare customers across the US, UK and Canada. Founded in 1984, headquartered in Vernon Hills, Illinois, ~15,100 employees, led by chair & CEO Christine A. Leahy. It is fundamentally a value-added reseller / solutions integrator: it sources hardware, software and cloud from thousands of vendors, layers on advisory, configuration, services and managed offerings, and sells the bundle. Fiscal year ends December 31.
Revenue mix (FY2025, from filings):
- By product/type: Total Hardware $16.07B (72%) · Software Products $4.20B (19%) · Services $2.04B (9%) · Other $0.11B. The business is still overwhelmingly hardware transaction volume — the low-margin, cyclical part — with a slowly growing, higher-value Services layer (Services up from $0.91B in 2020 to $2.04B in 2025).
- By geography: United States is the vast majority; Non-US (UK + Canada) $2.80B in FY25 (~12.5% of sales), the faster-growing piece (UK/Canada "Other" net sales +17.9% YoY in Q1'26 per the earnings release).
- By end-market (from the Q1'26 release): Commercial (Corporate + Small/Mid-Business) is the largest, then Government, Education, and Healthcare.
The strategic story management tells is a shift from box-mover toward "services-led, full-stack" advisor, riding an "AI-forward" adoption cycle as customers move from AI exploration into production. That transition is real but slow; hardware is still ~72% of the mix.
2. The expert thesis
There is no expert coverage for CDW in the Synthos knowledge base. total_claims = 0, zero net-bullish voices, zero cautionary voices. No All-In, Invest Like the Best, Jordi Visser, or any other tracked voice has a traceable claim on this name.
That is stated plainly and honestly: this verdict is entirely fundamentals- and quant-driven. There is no panel conviction — positive or negative — to lean on, and we do not manufacture any. Where a high-conviction name like LLY carries 250+ reconciled claims, CDW carries zero, and a reader should weight this note accordingly: it is a disciplined read of the financials, valuation, technicals and management guidance, nothing more. No claim_id values are cited anywhere in this document because none exist.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 5 · Moderate | Cheap (16× trailing, EV/EBITDA 12×), beta 0.99, ~1.9% yield and strong FCF cushion the downside — but net-debt/EBITDA 3.0× is real leverage, and this is a deeply cyclical IT-hardware reseller (−48% max drawdown, −26% trailing 12-mo). |
| Growth Quality | 5 · Average | Forward revenue CAGR only ~5% and EPS CAGR ~9%; gross margin a thin 21%, net margin ~5%. High ROE (42%) but that is leverage-flattered; ROIC ~12%. A well-run distributor, not a high-quality compounder. |
| Exponential Potential | 3 · Low | Mature, low-margin middleman in a slow-growth end-market; growth is flat-to-decelerating (revenue actually fell in 2023–24 before recovering), and a $17B cap in a commoditized niche has no multibagger runway. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities. EPS figures below are the non-GAAP diluted basis the Street and management use (FY25 ≈ $9.89; GAAP EPS was $8.08 diluted).
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | IT-spending re-accelerates; AI-infrastructure refresh + services mix lift margins; FY27E non-GAAP EPS beats to ~$12.9 and the multiple re-rates to ~15× as growth returns. | ~$195 (+46%) |
| Base (our anchor) | Estimates roughly hit — FY27E non-GAAP EPS ~$11.7; a steady mid-single-digit grower with a ~1.9% yield earns a ~13× multiple (its own history). | ~$150 (+12%) |
| Bear | Corporate/public IT budgets contract; hardware demand rolls over; FY27E EPS misses to ~$10.5 and the multiple de-rates to ~11× on cyclicality + leverage. | ~$110 (−17%) |
Synthos fair value = the base case, ~$150 (+12%), with the full $110–$195 span as the honest range. Our base happens to coincide with the Street's $150 consensus — not because we anchored to it, but because a mid-single-digit grower at ~13× forward earnings is close to fairly valued, and there is little analytical daylight to claim. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). CDW is neither — it is a mature, cyclical distributor:
- Forward growth: revenue CAGR FY25→FY29E ~5.0% ($22.3B → $27.1B); non-GAAP EPS CAGR FY25→FY28E ~9% ($9.89 → $12.70), the gap over revenue coming from buybacks and modest margin/mix improvement, not volume.
- Acceleration (the 2nd derivative) is absent: revenue fell in FY23 ($21.4B) and FY24 recovery was muted, before FY25 grew +6.8% and Q1'26 +9.2%. There is a cyclical recovery underway, but no structural acceleration — this is a company that tracks IT-budget cycles, not a secular ramp.
- Room to run: the US IT market is enormous, but CDW is a low-take-rate intermediary on it (EV/sales 0.99×, ~5% net margin). Management's own framing — "exceed US IT addressable-market growth by 200–300 bps" — is a share-gain-on-a-slow-market story, not a TAM-expansion story. That caps the ceiling.
- Reinvestment runway: capex is trivial (~0.5% of revenue); this is an asset-light, cash-return model (buybacks + dividend), which is shareholder-friendly but the opposite of a reinvest-for-hypergrowth engine.
Exponential Potential: Low (3/10). Own CDW, if at all, for value and income — never for a fast multibagger. A small, accelerating disruptor would score high here; CDW is a large, mature, decelerated-then-recovering middleman and scores low honestly.
5. Financials (real numbers — FMP annual/quarterly)
- Revenue: FY25 $22.42B, +6.8% (FY24 $21.00B; FY23 $21.38B; FY22 peak $23.75B). Note the cyclicality: revenue is below its 2022 peak three years later — this is not a straight-line grower.
- Quarterly trajectory: Q1'25 $5.20B → Q2 $5.98B → Q3 $5.74B → Q4 $5.51B → Q1'26 $5.68B (+9.2% YoY). Recovery is underway but seasonal/lumpy.
- Margins (thin, by design): gross 21.6% TTM (a distributor's spread), EBITDA margin ~8.1%, net margin ~4.7%. Gross margin actually slipped to 21.0% in Q1'26 on "lower netted-down revenue" mix.
- Earnings: GAAP net income $1.067B FY25, EPS $8.08 diluted (non-GAAP ~$9.89). Roughly flat-to-down vs FY22–23 ($1.10–1.11B) — earnings have been range-bound for years.
- Cash flow (the bright spot): operating CF $1.21B, capex only −$0.12B, FCF $1.09B FY25 (~6.4% FCF yield). Capital-light and cash-generative; FCF comfortably funds the dividend ($0.33B) and buybacks ($0.65B).
- Balance sheet: total debt $6.33B, net debt $5.71B, net-debt/EBITDA ~3.0× — meaningful leverage for a cyclical, and the main reason ROE (42%) looks elevated. Interest coverage ~14.5× is comfortable at current rates. Negative retained earnings / negative tangible book (goodwill-heavy from the LBO heritage).
6. Valuation — priced in or room?
CDW is one of the cheaper names in the Technology sector on trailing numbers: ~16× GAAP EPS, ~13.5× non-GAAP, EV/EBITDA 12.2×, EV/sales 0.99×, P/FCF ~15.8×, plus a ~1.9% dividend. On live consensus the forward P/E is roughly ~13× (FY26E, non-GAAP $10.74) → ~11× (FY27E $11.74). That is not demanding.
The honest catch is that cheap is appropriate here, not a mispricing: a ~5%-revenue-growth, ~5%-net-margin, 3.0×-levered cyclical should trade at a low-teens multiple. The PEG is unflattering (trailing PEG ~13 on near-zero recent earnings growth; forward PEG ~1.7). The FMP letter rating is B+ (overall score 3/5), dinged hardest on debt-to-equity (1/5) and price-to-book (2/5). Street targets (context): consensus $150, high $180, low $123 — our $150 base fair value coincides with consensus because there is genuinely little edge to claim. Verdict: fairly valued, mildly cheap — a value/income name, not a bargain with a catalyst.
7. Technicals (from the tech block)
- Trend: weak. $133.37 sits above the 50-DMA ($125.0) but below the 200-DMA ($135.0) — a stock trying to base after a downtrend, not a clean uptrend. MACD mildly positive (+3.3).
- Location: −27% off the 52-week high ($182.84), +34% off the 52-week low ($99.3). The max drawdown from peak was −48% — a stark reminder of the cyclicality.
- Momentum: RSI(14) 55 — neutral, neither overbought nor oversold.
- Relative strength (the tell, and it's negative): CDW −26.4% 12-mo vs SPY +20.6% and QQQ +30.3% — massive underperformance of both the market and tech. It has clawed back over 3 months (+9.9%) but still lags SPY (+13.7%) and QQQ (+22.0%) even there.
- Read: technicals do not confirm a bull case — this is a laggard basing below its 200-DMA. There is no technical urgency to buy; a reclaim of the 200-DMA (~$135) on volume would be the first constructive signal.
8. Moat & competitive position
CDW's moat is modest and scale-based, not structural: a huge vendor catalog, deep partner relationships, logistics/configuration scale, and sticky advisory relationships with ~250,000 customers. Switching costs exist at the solutions/services layer but are weak on commodity hardware, where the value-add is thin and price-transparent. The secular risks are real: vendor direct-sales and cloud marketplaces can disintermediate resellers, and hardware is structurally low-margin. The offsetting bull point is that complexity (multi-cloud, security, AI integration) keeps trusted integrators relevant — management's central pitch.
Peer set (market cap, from FMP — note: a mixed IT-services/software basket, not pure resellers): ON Semiconductor $35.7B, Corpay $23.0B, Wipro $19.8B, SS&C $15.8B, CGI $14.4B, Check Point $14.2B, Leidos $13.7B, GoDaddy $11.7B, Gartner $9.1B. The closest true comparables (Insight Enterprises, SHI, TD Synnex) are not in this FMP list; against this proxy basket CDW is mid-cap, lower-margin than the software/services names, and priced accordingly.
9. Management, capital allocation & guidance
- Capital allocation: shareholder-return-led and disciplined — FY25 returned ~$0.98B via buybacks ($0.65B) and dividends ($0.33B), funded comfortably by $1.09B FCF, while nudging debt down. Dividend raised to $0.63/quarter ($2.52 annualized, ~1.9% yield), ~30% payout. Capex is minimal. This is a sensible model for a mature, cash-generative distributor.
- Insider activity: the most recent Form 4 cluster (filed 2026-06-12, transactions 2026-06-10) is entirely routine annual equity awards ("A-Award") at $129.30 to directors and officers (CEO Leahy, CFO-adjacent officers, directors) — grants, not open-market buys or discretionary sells. No signal either way.
- Management's own guidance (the earnings-release track — half-weighted, self-interested): The SEC 8-K (Q1'26 earnings release, dated 2026-05-06) is a genuine earnings release and carries one explicit forward line: management reiterated confidence in its ability to "exceed US IT addressable market growth by 200 to 300 basis points on a constant-currency basis." CEO Leahy framed the year around customers moving "from AI exploration into real, production environments" and CDW's "services-led, full-stack" positioning; CFO Miralles emphasized "disciplined working-capital management" and "strong cash flow and capital flexibility." Treat as management's own book (half-weight): this is a relative share-gain target, not a hard revenue/EPS number, and it presumes a positive underlying IT-market growth rate the company does not itself control.
10. Catalysts & what to watch
- Next earnings: 2026-08-05 (Q2'26; Street non-GAAP EPS $2.80, revenue ~$6.20B). Watch the YoY growth rate and gross-margin mix (netted-down revenue) closely.
- IT-spending cycle: the single biggest driver — corporate/government/education/healthcare tech-budget direction. The Q1'26 release flagged all segments improving; a reversal is the key bear trigger.
- AI-infrastructure refresh: whether "AI exploration → production" actually converts into hardware + services revenue at scale, and whether it lifts the services mix (margin).
- Margin mix: Services growing faster than Hardware would be the constructive structural tell; Q1'26 gross margin slipping to 21.0% is the caution.
- Capital returns: continued buyback pace and dividend growth as a floor under the stock.
Thesis tripwires (what would change the call): two consecutive quarters of revenue decline (cycle rolling over); net-debt/EBITDA rising above ~3.5×; gross margin eroding below ~20.5%; or, on the upside, a durable re-acceleration to double-digit revenue growth with services-led margin expansion (which would push this toward Buy — Tactical).
11. Key risks
- Cyclicality (structural): CDW's revenue tracks IT-hardware budgets; it fell below its 2022 peak for years and the stock drew down 48% from its high. A macro/IT-spend downturn hits sales and earnings directly.
- Leverage: net-debt/EBITDA ~3.0× on a cyclical is the balance-sheet risk; the FMP model scores debt-to-equity 1/5.
- Thin margins / disintermediation: ~21% gross and ~5% net leave little cushion; vendor-direct and cloud-marketplace models are a standing secular threat to resellers.
- Low growth: ~5% forward revenue CAGR gives little room for multiple expansion; the equity story depends on buybacks and cycle timing.
- No expert conviction: the Synthos KB has zero claims on CDW — there is no independent panel signal, positive or negative, so the call rests solely on quant/fundamentals.
12. Verdict, position sizing & monitoring
Watch. CDW is a well-managed, cash-generative, reasonably cheap IT distributor with a safe ~1.9% dividend — genuinely fine, and nothing is broken. But it is a thin-margin, cyclical, mid-single-digit grower with meaningful leverage, a technical downtrend (−26% trailing vs SPY +21%), fair-not-cheap valuation once you adjust for the cycle, and — critically — no expert conviction in our KB to justify a Buy rating. Our base fair value (~$150) coincides with the Street's, implying limited edge and roughly +12% upside — not enough asymmetry, given the cyclicality, to chase.
- Sizing: if held at all, a small (~1–2%) value/income position, not a core or growth holding. This is a name to watch for a cheaper entry (toward the low-$120s / the Street's $123 low) or a clear cyclical/technical turn, not to accumulate here.
- Monitoring: re-underwrite on the tripwires in §10; formal re-score each earnings print. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $133.37.
- Single biggest risk: a corporate/public-sector IT-spending downturn — CDW is a levered, thin-margin play on hardware demand.
Provenance & disclosures
- Traceability: 0 KB claims, breadth 0 — no expert coverage exists for CDW in the Synthos knowledge base, so no
claim_idvalues are cited. The verdict is explicitly fundamentals- and quant-driven. Fabricated conviction is structurally impossible (claim-ID reconciliation) and none is asserted. - Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · no expert claims. Forward figures are analyst consensus (FMP), labeled as estimates; EPS scenario figures are on a non-GAAP diluted basis unless noted.
- Management caveat: the §9 guidance is management's own earnings-release language (SEC 8-K, 2026-05-06), half-weighted by design and framed as a relative share-gain target, not a hard forecast.
- Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
- Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").